Key Points
- Dr. Martens insider Ije Nwokori sold 209,160 shares at an average of GBX 69, generating proceeds of approximately £144,320.
- The company’s shares opened at GBX 68.80, with a market capitalization of about £658.5 million and a 52-week range of GBX 59.15 to GBX 97.05.
- Analyst sentiment remains positive: Berenberg reaffirmed a “Buy” rating with a GBX 110 target, while the consensus rating is “Moderate Buy” with an average target of GBX 105.
Dr. Martens plc (LON:DOCS - Get Free Report) insider Ije Nwokori sold 209,160 shares of the stock in a transaction dated Friday, October 16th. The stock was sold at an average price of GBX 69, for a total value of £144,320.40.
Ije Nwokori also recently made the following trade(s):
- On Monday, October 12th, Ije Nwokori purchased 220 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 68 per share, for a total transaction of £149.60.
- On Friday, September 11th, Ije Nwokori purchased 232 shares of Dr. Martens stock. The stock was acquired at an average price of GBX 65 per share, with a total value of £150.80.
- On Tuesday, August 11th, Ije Nwokori purchased 179 shares of Dr. Martens stock. The stock was acquired at an average price of GBX 84 per share, with a total value of £150.36.
Dr. Martens Trading Up 0.9%
Shares of DOCS stock opened at GBX 68.80 on Friday. The firm's 50-day simple moving average is GBX 73.05 and its 200-day simple moving average is GBX 71.03. The company has a debt-to-equity ratio of 108.85, a current ratio of 2.61 and a quick ratio of 1.13. Dr. Martens plc has a 1-year low of GBX 59.15 and a 1-year high of GBX 97.05. The firm has a market cap of £658.53 million, a P/E ratio of 28.67, a PEG ratio of 6.40 and a beta of 0.26.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reaffirmed a "buy" rating and set a GBX 110 price target on shares of Dr. Martens in a research note on Friday, October 9th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of GBX 105.
Get Our Latest Research Report on Dr. Martens
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
